Oxidative stress in chronic lymphocytic leukemia: still a matter of debate.
Giovanni D'ArenaElisa SenecaIlaria MigliaccioVincenzo De FeoAldo GiudiceFrancesco La RoccaMario CapunzoGioacchino CalapaiAgostino FestaMichele CaragliaPellegrino MustoEugenio Luigi IorioVitalba RuggieriPublished in: Leukemia & lymphoma (2018)
There is a large body of evidence showing a strong correlation between carcinogenesis of several types of human tumors, including chronic lymphocytic leukemia (CLL), and oxidative stress (OS). The mechanisms by which OS may promote cancer pathogenesis have not been completely deciphered yet and, in CLL, as in other neoplasms, whether OS is a primary cause or simply a downstream effect of the disease is still an open question. It has been demonstrated that, in CLL, OS concomitantly results from increased reactive oxygen species (ROS) production, mainly ascribable to CLL cells mitochondrial activity, and impaired antioxidant defenses. Interestingly, OS evaluation in CLL patients, at diagnosis, seems to have a prognostic significance, thus getting new insights in the biological comprehension of the disease with potential therapeutic implications.
Keyphrases
- chronic lymphocytic leukemia
- oxidative stress
- induced apoptosis
- reactive oxygen species
- dna damage
- end stage renal disease
- ejection fraction
- ischemia reperfusion injury
- endothelial cells
- diabetic rats
- newly diagnosed
- chronic kidney disease
- cell death
- endoplasmic reticulum stress
- papillary thyroid
- prognostic factors
- peritoneal dialysis
- signaling pathway
- cell cycle arrest
- young adults
- patient reported
- pluripotent stem cells